(Wyss Institute for Biologically Inspired Engineering at Harvard) Harvard University has granted a worldwide exclusive license to Sherlock Biosciences Inc. to develop and commercialize technology from the Wyss Institute for Biologically Inspired Engineering to create a highly sensitive, nucleic acid-based diagnostic platform that can rapidly deliver accurate and inexpensive results for a vast range of needs in virtually any setting.

Original source: https://www.eurekalert.org/pub_releases/2019-03/wifb-sbl031919.php